Anti-amyloid antibodies lecanemab and donanemab are in clinical use now, but that does not mean research on them has stopped. At the Clinical Trials on Alzheimer’s Disease conference, held October ...
Alzheimer's researchers are widening the scope of biomarkers used to detect Alzheimer's and dementia. In a recent research update, the Alzheimer's Association a ...
According to research published in 2004 in the journal Alzheimer’s Disease and Associated Disorders, a normal score for individuals without Alzheimer’s or other types of dementia typically hovers ...